Nordhealth AS (OSL:NORDH) Beta: -0.4092 (As of Jun. 30, 2026)


OSL:NORDH Nordhealth AS OSL:NORDH
75 GF Score
Price kr25.60
GF Value kr38.75
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Nordhealth AS Beta?

Nordhealth AS OSL:NORDH 75 Beta is -0.4092 as of Jun. 30, 2026. GuruFocus rates OSL:NORDH with a GF Score™ of 75/100 and a GF Value™ of kr38.75 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Nordhealth AS's Beta is -0.4092.


Nordhealth AS  (OSL:NORDH) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Nordhealth AS Beta Related Terms


Nordhealth AS Beta Historical Data

* Premium members only.

The historical data trend for Nordhealth AS's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nordhealth AS Beta Chart

Nordhealth AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.07 -0.04

Nordhealth AS Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.30 -0.01 -0.04 -0.60

OSL:NORDH vs VEEV, BTSG, TEM: Beta Comparison

For the Health Information Services subindustry, Nordhealth AS's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nordhealth AS Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nordhealth AS's Beta distribution charts can be found below:

* The bar in red indicates where Nordhealth AS's Beta falls into.


OSL:NORDH
75GF Score
Nordhealth AS OSL:NORDH
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nordhealth AS Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.4092 mean?
Nordhealth AS (OSL:NORDH) has a Beta of -0.4092 as of Jun. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Nordhealth AS and its competitors.
Is Nordhealth AS's Beta too high?
Nordhealth AS's current Beta is -0.4092. Overall, Nordhealth AS has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's Beta compare to VEEV and BTSG?
Nordhealth AS's Beta of -0.4092 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Nordhealth AS and its competitors. Nordhealth AS's current Beta is -0.4092. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Based on GuruFocus' analysis, Nordhealth AS (OSL:NORDH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr38.75, compared to a current price of kr25.60 — trading 33.9% below its estimated fair value. The current Beta is -0.4092. Nordhealth AS's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Nordhealth AS (OSL:NORDH), the current Beta is -0.4092 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nordhealth AS (OSL:NORDH) Overvalued in 2026?

Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued. The current stock price of kr25.60 is trading 33.9% below its estimated GF Value™ of kr38.75. GuruFocus considers Nordhealth AS to be Significantly Undervalued.

Key valuation signals for OSL:NORDH:

  • Beta: -0.4092
  • GF Value™: kr38.75 vs. price of kr25.60 (33.9% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the OSL:NORDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nordhealth AS Business Description

Address Hasleveien 28A, Oslo, NOR, 0571
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
75GF Score

Get the complete analysis for OSL:NORDH

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr25.60
Price
kr38.75
GF Value